Dr Basho on Treatment Considerations With ADCs in Breast Cancer
Reva K Basho, MD, discusses the use of antibody-drug conjugates across the spectrum of breast cancer subtypes at the 2023 Bridging the Gaps in Breast Cancer meeting.
Source: onclive.com